Published in Vaccine Weekly, October 26th, 2005
According to recent research from Israel, "Do autoantibodies against glutamate/AMPA receptor subtype 3 affect the severity of seizures' Rats immunized with the GluR3B-peptide [amino acids (aa) 372-395] or with the control GluR3A-peptide (aa 245-274) produced the respective anti-GluR3B and anti-GluR3A antibodies (both types of autoantibodies found in some epilepsy patients). The GluR3B-immunized rats exhibited neuronal death and reactive gliosis in the brain, but not overt spontaneous seizures."
Yonatan Ganor and his...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly